108 related articles for article (PubMed ID: 22938427)
1. The MTHFR C677T polymorphism and prostate cancer risk: new findings from a meta-analysis of 7306 cases and 8062 controls.
Zhang WB; Zhang JH; Pan ZQ; Yang QS; Liu B
Asian Pac J Cancer Prev; 2012; 13(6):2597-604. PubMed ID: 22938427
[TBL] [Abstract][Full Text] [Related]
2. The protective effect of methylenetetrahydrofolate reductase C677T polymorphism against prostate cancer risk: Evidence from 23 case-control studies.
Guo S; Jiang X; Chen X; Chen L; Li X; Jia Y
Gene; 2015 Jul; 565(1):90-5. PubMed ID: 25841988
[TBL] [Abstract][Full Text] [Related]
3. Association between MTHFR C677T Polymorphism and Risk of Prostate Cancer: Evidence from 22 Studies with 10,832 Cases and 11,993 Controls.
Abedinzadeh M; Zare-Shehneh M; Neamatzadeh H; Abedinzadeh M; Karami H
Asian Pac J Cancer Prev; 2015; 16(11):4525-30. PubMed ID: 26107198
[TBL] [Abstract][Full Text] [Related]
4. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
Zhang J; Qiu LX; Wang ZH; Wu XH; Liu XJ; Wang BY; Hu XC
Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
[TBL] [Abstract][Full Text] [Related]
5. Association between MTHFR gene polymorphisms (C677T, A1298C) and genetic susceptibility to prostate cancer: a meta-analysis.
Chen PL; Li WT; Wang J; Jiang YD; Wu P; Chen T; Zheng SB
Genet Mol Res; 2015 Dec; 14(4):19191-202. PubMed ID: 26782572
[TBL] [Abstract][Full Text] [Related]
6. Association between Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to cervical cancer: a meta-analysis.
Yu L; Chang K; Han J; Deng S; Chen M
PLoS One; 2013; 8(2):e55835. PubMed ID: 23431363
[TBL] [Abstract][Full Text] [Related]
7. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
Yi K; Yang L; Lan Z; Xi M
Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
[TBL] [Abstract][Full Text] [Related]
8. Association of the methylenetetrahydrofolate reductase gene C677T polymorphism with the risk of male infertility: a meta-analysis.
Zhu X; Liu Z; Zhang M; Gong R; Xu Y; Wang B
Ren Fail; 2016; 38(2):185-93. PubMed ID: 26584688
[TBL] [Abstract][Full Text] [Related]
9. Methylenetetrahydrofolate reductase polymorphisms and susceptibility to esophageal cancer in Chinese populations: a meta-analysis.
Yang YB; Shang YH; Tan YL; Kang XJ; Meng M; Zhao ZX
Asian Pac J Cancer Prev; 2014; 15(3):1345-9. PubMed ID: 24606463
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between MTHFR C677T Gene polymorphism with alcohol dependence: A meta-analysis of case-control studies.
Xu R; Wu H; Zhang S; Zhou H; Liang L
Neurosci Lett; 2018 Sep; 683():69-74. PubMed ID: 29953924
[TBL] [Abstract][Full Text] [Related]
11. Association between MTHFR gene polymorphisms and the risk of autism spectrum disorders: a meta-analysis.
Pu D; Shen Y; Wu J
Autism Res; 2013 Oct; 6(5):384-92. PubMed ID: 23653228
[TBL] [Abstract][Full Text] [Related]
12. Association between MTHFR C677T polymorphism and risk of acute lymphoblastic leukemia: a meta-analysis based on 51 case-control studies.
Li SY; Ye JY; Liang EY; Zhou LX; Yang M
Med Sci Monit; 2015 Mar; 21():740-8. PubMed ID: 25761797
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.
Qi X; Ma X; Yang X; Fan L; Zhang Y; Zhang F; Chen L; Zhou Y; Jiang J
Breast Cancer Res Treat; 2010 Sep; 123(2):499-506. PubMed ID: 20135343
[TBL] [Abstract][Full Text] [Related]
14. Association of C677T polymorphism (rs1801133) in MTHFR gene with depression.
Rai V
Cell Mol Biol (Noisy-le-grand); 2017 Jul; 63(6):60-67. PubMed ID: 28968218
[TBL] [Abstract][Full Text] [Related]
15. Allele and Genotype Frequencies of the Polymorphic Methylenetetrahydrofolate Reductase and Lung Cancer in ther Jordanian Population: a Case Control Study.
Al-Motassem Y; Shomaf M; Said I; Berger S; Ababneh N; Diab O; Obeidat N; Awidi A
Asian Pac J Cancer Prev; 2015; 16(8):3101-9. PubMed ID: 25921104
[TBL] [Abstract][Full Text] [Related]
16. Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to epilepsy.
Rai V; Kumar P
Neurol Sci; 2018 Dec; 39(12):2033-2041. PubMed ID: 30267335
[TBL] [Abstract][Full Text] [Related]
17. Association of methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism with autism: evidence of genetic susceptibility.
Rai V
Metab Brain Dis; 2016 Aug; 31(4):727-35. PubMed ID: 26956130
[TBL] [Abstract][Full Text] [Related]
18. The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study.
Reljic A; Simundic AM; Topic E; Nikolac N; Justinic D; Stefanovic M
Clin Biochem; 2007 Sep; 40(13-14):981-5. PubMed ID: 17573062
[TBL] [Abstract][Full Text] [Related]
19. Methylenetetrahydrofolate reductase C677T polymorphism and congenital heart disease: a meta-analysis.
Nie Y; Gu H; Gong J; Wang J; Gong D; Cong X; Chen X; Hu S
Clin Chem Lab Med; 2011 Dec; 49(12):2101-8. PubMed ID: 21793799
[TBL] [Abstract][Full Text] [Related]
20. Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism and Alzheimer Disease Risk: a Meta-Analysis.
Rai V
Mol Neurobiol; 2017 Mar; 54(2):1173-1186. PubMed ID: 26820674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
